van Rijn, Richard M

Back to all technologies

Innovations

Innovation Title Categories Lead Inventor
Tool to Rapidly Discover Biased Agonists of Delta Opioid Receptor and Other G Protein-Coupled Receptors
2021-VANR-69275
  1. Biotechnology
  2. Pharmaceuticals
van Rijn, Richard M
Novel Adenylyl Cyclase 1 Inhibitors for Treatment of Chronic Pain
2020-FLAH-68825
  1. Pharmaceuticals
Flaherty, Daniel P P.
Non-Opioid for Treating Chronic Pain and Opioid Dependence
2017-WATT-67867
  1. Pharmaceuticals
Watts, Val J
Novel Adenylyl Cyclase 1 Inhibitors for Chronic Pain and Opioid Dependence
2017-WATT-67991
  1. Pharmaceuticals
Watts, Val J
Simultaneous Treatment of Alcohol Use and Psychiatric Disorders
2017-VANR-67884
  1. Pharmaceuticals
  2. Medical/Health
van Rijn, Richard M

Details

Dr. Richard M. van Rijn is an Associate Professor of Medicinal Chemistry and Molecular Pharmacology at Purdue University. He earned a B.S. and M.S. in Biopharmaceutical Sciences at Leiden University, Leiden, Netherlands, and a Ph.D. in Molecular Pharmacology from Vrije Universiteit Amsterdam. Dr. van Rijn's research focuses on understanding the development of drug dependence, long-term effects of chronic drug abuse on neuropharmacology, and the effect that neurological disorders have on the progression of drug dependence. His goal is to develop new pharmaceuticals that may assist in treating drug dependence. Current research projects include investigation into the role of beta-arrestin dependent signaling in depression and anxiety disorders, opioid and alcohol use disorders, chronic pain disorders, locomotor dysfunction, seizures, and developing novel opioid therapeutic leads through natural products and de novo synthesis.

For additional information, visit Dr. Van Rijn's Purdue website: http://www.mcmp.purdue.edu/faculty/?uid=rvanrijn
or his Van Rijn Lab website: http://www.vanrijnlab.com/